These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 2505777)

  • 1. Polyamine synthesis blockade in monocrotaline-induced pneumotoxicity.
    Olson JW; Orlinska U; Gillespie MN
    Biochem Pharmacol; 1989 Sep; 38(17):2903-10. PubMed ID: 2505777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of deoxyribonucleic acid synthesis by difluoromethylornithine. Role of polyamine metabolism in monocrotaline-induced pulmonary hypertension.
    Hacker AD
    Biochem Pharmacol; 1992 Sep; 44(5):965-71. PubMed ID: 1530663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of polyamine biosynthesis prevents monocrotaline-induced pulmonary edema and arterial medial thickening.
    Olson JW; Atkinson JE; Hacker AD; Altiere RJ; Gillespie MN
    Toxicol Appl Pharmacol; 1985 Oct; 81(1):91-9. PubMed ID: 3931300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
    Orlinska U; Olson JW; Gillespie MN
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyamines and the development of monocrotaline-induced pulmonary hypertension.
    Olson JW; Hacker AD; Altiere RJ; Gillespie MN
    Am J Physiol; 1984 Oct; 247(4 Pt 2):H682-5. PubMed ID: 6437245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs.
    Gillespie MN; Dyer KK; Olson JW; O'Connor WN; Altiere RJ
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):365-78. PubMed ID: 3936139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension.
    Hacker AD
    Biochem Pharmacol; 1993 Jun; 45(12):2475-81. PubMed ID: 8328985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Difluoromethylornithine attenuates monocrotaline-induced airway/lung dysfunction.
    Zhou KR; Lai YL
    J Appl Physiol (1985); 1992 May; 72(5):1914-21. PubMed ID: 1601800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylated polyamines in lungs from rats with monocrotaline-induced pneumotoxicity.
    Orlinska U; Olson JW; Gebb SA; Gillespie MN
    Fundam Appl Toxicol; 1989 Aug; 13(2):277-84. PubMed ID: 2507383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyamines and epidermal growth factor in monocrotaline-induced pulmonary hypertension.
    Gillespie MN; Rippetoe PE; Haven CA; Shiao RT; Orlinska U; Maley BE; Olson JW
    Am Rev Respir Dis; 1989 Nov; 140(5):1463-6. PubMed ID: 2510568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged activation of rat lung ornithine decarboxylase in monocrotaline-induced pulmonary hypertension.
    Olson JW; Altiere RJ; Gillespie MN
    Biochem Pharmacol; 1984 Nov; 33(22):3633-7. PubMed ID: 6439208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyamine synthesis in rat lungs injured with alpha-naphthylthiourea.
    Olson JW; Gebb SA; Orlinska U; Gillespie MN
    Toxicology; 1989 May; 55(3):317-26. PubMed ID: 2497556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Polyamine Uptake Potentiates the Anti-Proliferative Effect of Polyamine Synthesis Inhibition and Preserves the Contractile Phenotype of Vascular Smooth Muscle Cells.
    Grossi M; Phanstiel O; Rippe C; Swärd K; Alajbegovic A; Albinsson S; Forte A; Persson L; Hellstrand P; Nilsson BO
    J Cell Physiol; 2016 Jun; 231(6):1334-42. PubMed ID: 26529275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that hypoxic pulmonary vascular remodeling in rats is polyamine dependent.
    Atkinson JE; Olson JW; Altiere RJ; Gillespie MN
    J Appl Physiol (1985); 1987 Apr; 62(4):1562-8. PubMed ID: 3110122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
    Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monokine-induced lung injury in rats: similarities to monocrotaline-induced pneumotoxicity.
    Gillespie MN; Olson JW; Hennig B; Cohen DA; McClain CJ; Goldblum SE
    Toxicol Appl Pharmacol; 1989 Mar; 98(1):134-43. PubMed ID: 2494779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamines, vascular smooth muscle, and deoxycorticosterone acetate-salt hypertension.
    Soltis EE; Newman PS; Olson JW
    Hypertension; 1991 Jul; 18(1):85-92. PubMed ID: 1860716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response.
    Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA
    Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eflornithine treatment in SHR: potential role of vascular polyamines and ornithine decarboxylase in hypertension.
    Soltis EE; Newman PS; Olson JW
    Clin Exp Hypertens; 1994 Sep; 16(5):595-610. PubMed ID: 7951165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminal polyamines substitute for tissue polyamines in duodenal mucosal repair after stress in rats.
    Wang JY; Johnson LR
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1109-17. PubMed ID: 1551519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.